AAO keynote weighs AI’s clinical promise against the need for human oversight

A clinical conversation at AAO

Robert M. Wachter discussed AI’s role in health care during an October 10 keynote at the American Academy of Ophthalmology meeting. AJMC’s report describes his argument for informed optimism while keeping physicians responsible for interpreting the output.

Wachter presented AI as a potential way to make specialist knowledge easier to consult. That is a view expressed in a conference address. Readers should distinguish the speaker’s expectations from evidence that a specific product improves care for a particular patient group.

Where the proposed benefits sit

The report describes record summarization and support for clinical decisions among the uses Wachter discussed. He argued that tools could help physicians manage lengthy patient histories and the volume of medical information they encounter.

Those proposals offer concrete questions for a hospital evaluating software. Can a clinician trace a summary back to the record? Does the system preserve an uncertainty or contradiction that affects the decision? A shorter document is useful only if the person responsible for care can identify what it omits and what still needs attention.

Oversight remains part of the work

Wachter also discussed privacy, security and misinformation concerns. AJMC reports that he sees physicians as an essential safeguard when AI gives incorrect advice. His confidence in future capabilities should be read alongside that continuing need for judgment.

For an institution considering a trial, the relevant next step would be an evaluation suited to the exact task, with clear responsibility for reviewing the result. Administrative assistance and clinical recommendations can have different consequences when something goes wrong. The keynote offers a perspective on the direction of the field; it does not supply a universal accuracy figure or establish that an AI system can replace a clinician’s assessment.